02.10.2017 | PHASE I STUDIES
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer
Erschienen in: Investigational New Drugs | Ausgabe 3/2018
Einloggen, um Zugang zu erhalten